VEGFA and chronic recurrent multifocal osteomyelitis: Alternative therapies such as NSAIDs or anti-VEGF agents demonstrated limited benefit, highlighting a non-inflammatory pathogenesis.<h4>Conclusions</h4>Nab-paclitaxel-induced CMO is a rare but reversible condition that requires prompt cessation.